Pediatric antidepressant medication errors in a national error reporting database.

Area of Science:

• Pediatric pharmacology
• Medication safety
• Health outcomes research

Background:

• Medication errors in pediatric populations pose significant risks.
• Antidepressant use in children and adolescents requires careful monitoring.
• Understanding error patterns is crucial for improving patient safety.

Purpose of the Study:

• To characterize the nature and frequency of antidepressant medication errors in pediatric patients.
• To identify common causes and contributing factors in these errors.
• To compare error types between inpatient and outpatient settings.

Main Methods:

• Analysis of United States Pharmacopeia MEDMARX database error reports.
• Inclusion of reports involving antidepressant medications and patients under 18 years old.
• Data collected from 2003 to 2006.

Main Results:

• Of 451 identified errors, 95% reached the patient; 6.4% caused increased monitoring/treatment needs.
• Off-label use was involved in 77% of errors.
• Administering (33%), dispensing (30%), and transcribing (28%) were primary error causes. Sertraline, bupropion, fluoxetine, and trazodone were most common.
• Harmful errors were associated with administration, inpatient settings, and extra doses.
• Outpatient errors more frequently involved dispensing and transcription issues.

Conclusions:

• Pediatric antidepressant errors are common, often reach patients, and frequently involve off-label prescribing.
• Error characteristics vary by medication and care setting (inpatient vs. outpatient).
• Enhanced education, prompt error disclosure, and targeted reduction strategies are essential.